Progyny, Inc.
PGNYNASDAQHealthcare● Active
$25.85
$-0.01(-0.02%)
Market Cap$2.0B
P/E Ratio—
52W High$28.75
52W Low$16.1
Progyny, Inc. (PGNY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PGNY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.29B | $1.17B | $1.09B | $0.79B | $0.50B |
| Cost of Revenue | $0.98B | $0.91B | $0.85B | $0.62B | $0.39B |
| Gross Profit | $0.30B | $0.25B | $0.24B | $0.17B | $0.11B |
| Gross Margin %(computed) | 23.63% | 21.71% | 21.94% | 21.26% | 22.40% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.15B | $0.12B | $0.12B | $0.10B | $0.06B |
| Total Operating Expenses | $0.22B | $0.19B | $0.18B | $0.14B | $0.08B |
| Operating Income | $0.09B | $0.07B | $0.06B | $0.02B | $0.03B |
| Operating Margin %(computed) | 6.62% | 5.78% | 5.71% | 2.97% | 6.46% |
| Interest Income | $0.00B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.10B | $0.08B | $0.07B | $0.02B | $0.03B |
| Income Tax Expense | $0.04B | $0.03B | $0.01B | ($0.01B) | ($0.03B) |
| Net Income | $0.06B | $0.05B | $0.06B | $0.03B | $0.07B |
| Net Margin %(computed) | 4.54% | 4.66% | 5.70% | 3.86% | 13.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.68 | $0.59 | $0.65 | $0.33 | $0.74 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.10B | 0.09B | 0.09B |
| EBITDA | $0.10B | $0.07B | $0.06B | $0.02B | $0.03B |
| EBITDA Margin %(computed) | 7.79% | 6.05% | 5.92% | 3.17% | 6.72% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Progyny, Inc. data
About Progyny, Inc. (PGNY) Income Statement
Progyny, Inc. (PGNY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PGNY reported revenue of $1.29B, gross profit of $0.30B (gross margin 23.63%), and net income of $0.06B — a net profit margin of 4.54%.
Frequently asked questions
PGNY · 4 questionsProgyny, Inc. (PGNY) reported revenue of $1.29B for 2025, up 10.4% year-over-year.
PGNY revenuePGNY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08